Articles tagged with Cancer
Research from Hiroshima University Hospital found that YAP/TAZ interactions with RBM39 delay the degradation of RBM39 by indisulam, thereby reducing its effectiveness and conferring resistance. This mechanism may aid the development of a new therapeutic approach for patients with solid cancers including HNSCC.
A recent study published in Frontiers found that pesticide use is associated with increased cancer risk, particularly for Non-Hodgkins lymphoma, leukemia, and bladder cancer. The researchers discovered a strong correlation between pesticide exposure and cancer incidence, rivalling the effects of smoking.
Researchers found that type II innate lymphoid cells transform after a cancer patient receives stem cells from a donor, preventing an effective immune system rebuilding. This new understanding may lead to better strategies for enhancing immune system recovery post-transplantation.
Women with bilateral mastectomy have a greatly diminished risk of contralateral breast cancer, yet experience similar mortality rates as patients treated with lumpectomy or unilateral mastectomy. The study highlights the importance of considering long-term risks and benefits in breast cancer treatment decisions.
The American College of Chest Physicians has released a new clinical guideline for managing central airway obstruction, providing evidence-based recommendations to guide its management. The guideline emphasizes the importance of shared decision-making and a multidisciplinary approach in optimizing care and improving outcomes.
A new AI model can identify certain stages of ductal carcinoma in situ (DCIS), a type of pre-invasive breast cancer, that are likely to progress to invasive cancer. The model uses imaging and machine learning to analyze tissue samples and determine the stage of DCIS based on cell arrangement and organization.
A new study published in Aging explores the potential of three large DNA methylation datasets to identify biological age signals in dogs. The researchers found that biological age methylation clocks are affected by population stratification and require heavy parameterization to achieve effective predictions.
A team of researchers from Penn State College of Medicine identified KDR, a tyrosine kinase, as a potential drug target for treating diseases caused by human T-cell leukemia virus type 1 (HTLV-1). By blocking KDR, the viral protein Tax is degraded, leading to cell death and disruption of cancer-causing signaling pathways.
A novel strategy using venetoclax and azacitidine demonstrates significant anti-cancer effect with mild toxicity for relapsed/refractory AML patients. The treatment showed markedly better survival rates after one year compared to a control group, with improved 'graft-versus-leukemia effects' via alterations of immune cells.
Researchers created a new cell model to study the effects of senescence on lung fibroblasts. Senescent alveolar epithelial cells triggered fibrotic activation in lung fibroblasts, which was attenuated by senolytic therapy.
Researchers discovered that deactivating IL-11 increases healthy lifespan by 20-25% in mice, with reduced cancer deaths, fibrosis, chronic inflammation, and improved muscle strength. The findings raise the possibility of using anti-IL-11 treatments to study aging in humans.
Research reveals that ancient viruses can play a critical role in helping cancer survive and thrive. Silencing certain endogenous retroviruses may make cancer treatments work better by turning off nearby gene expression.
Experts have established a comprehensive guideline for classifying and treating advanced liver cancer in China. The guidelines recommend personalized treatment options based on tumor characteristics, vascular tumor thrombus grade, distant metastasis, liver function status, portal hypertension, and hepatitis B virus replication status.
A new study found that an electronic health record (EHR)-based nudge intervention significantly decreased low-value axillary surgery in older women with clinically node-negative, HR+/HER2− breast cancer. The user-friendly intervention could be beneficial for other practice settings or patient populations.
The study found that exercise increased PEDF levels in skeletal muscles and suppressed senescence markers in the lungs. PEDF also reduced senescence markers in multiple tissues and attenuated decline in respiratory function in pulmonary emphysema mouse model, suggesting its potential as a therapeutic agent for age-related diseases.
A retrospective cohort study found hormone-modulating therapy protected against Alzheimer's disease and related dementias in postmenopausal women with breast cancer. The protective effect varied by age and race, with greater benefit for Black women under 75.
A cross-sectional study found that men from disadvantaged neighborhoods had higher stress-related gene expression in their prostate tumors. This association suggests a potential link between neighborhood factors and aggressive prostate cancer.
Researchers at the University of Plymouth have discovered that administering a HDAC6 inhibitor prior to radiotherapy can inhibit cellular growth and increase cell death in meningioma samples. This promising approach could lead to improved treatment outcomes for malignant meningioma patients.
Researchers found increased liver oxidative stress and impaired antioxidant defenses in a DS murine model. The study suggests potential therapeutic strategies targeting oxidative stress and lipid metabolism to prevent or mitigate liver-related complications.
Researchers investigate chemical modifications to genetic regulation mechanisms, finding that Set8 controls gene activity through a mechanism other than histone modification. This study refines our understanding of genetic regulation relevant to human diseases like cancer.
Researchers discuss the critical role of the retinal pigmented epithelium in human vision and its susceptibility to aging. The study highlights the importance of understanding molecular and cellular mechanisms driving age-related pathological changes in vision decline.
Researchers have found that blocking Interleukin-6 (IL-6) from binding to neurons in the area postrema prevents cachexia in mice. This breakthrough discovery could lead to the development of new drugs targeting these neurons, potentially treating cancer cachexia and improving patients' quality of life.
The study identified RNF144B as a tumour suppressor that prevents genomic instability, but low expression leads to poor prognosis and treatment resistance in lung adenocarcinoma. The research suggests that even non-mutated genes like RNF144B can have a significant impact on cancer development.
Researchers found GLP-1 receptor agonists lower risks of certain obesity-associated cancers in patients with type 2 diabetes, suggesting potential benefits for cancer prevention in high-risk populations. The study provides preliminary evidence supporting further preclinical and clinical studies to prevent specific obesity-linked cancers.
A team of Penn State researchers has created a modular genetic circuit that turns cancer cells into a 'Trojan horse,' causing them to self-destruct and kill nearby drug-resistant cancer cells. The circuit outsmarts resistance and eliminates it before the cancer cells can evolve.
A study led by UPF describes the mechanism behind insulinoma formation, a rare type of pancreatic beta cell tumor. The research reveals that a change in the epigenetic pattern of beta cells leads to the accumulation of mutations and excessive insulin production.
A new genomic test has improved clinical care for some children with cancer in England by informing individual patient care. The study found that the test provided additional insights that improved care for 20 children and reduced the number of tests required.
The study identified 72 genes commonly expressed in chronically activated CD8+ T cells across seven types of cancer. One gene, CXCR6, supports the survival of these cells by promoting CD28 signaling. This finding may inform targets for broadly active cancer therapies and treatments.
An Italian study found that adherence to the Mediterranean Diet after a cancer diagnosis is associated with reduced mortality, especially from cardiovascular disease. Participants who followed a high-Mediterranean-Diet pattern had a 32% lower risk of mortality compared to those with lower adherence.
The University of Texas at Arlington's Junha Jeon is developing transition metal-free cross-coupling technologies using arynes to deliver medications safely and effectively. This project aims to improve the production of drugs, particularly for cancer treatment, by reducing impurities left behind by metals.
A new study has identified potential cancer drivers hidden in so-called 'junk' regions of DNA, which could lead to early diagnosis and new treatments. The discovery reveals mutations in previously overlooked regions of the genome that may contribute to the formation and progression of at least 12 different cancers.
A phase 2 study found fluorine-18 PSMA-1007 PET/computed tomography to be superior to multiparametric MRI for locoregional staging of prostate cancer. The technology supports its use in the preoperative workflow for intermediate-risk and high-risk tumors.
Researchers develop optogenetic system to precisely target cancer cells using light, inducing inflammatory cell death and triggering immune response. The approach aims to modulate the immune suppressive environment around cancer cells, helping T cells recognize and attack the disease.
A new liquid biopsy method analyzes gene fragments in the bloodstream to detect and track cancer, enabling oncologists to tailor treatment approaches to individual patients. This non-invasive test can help monitor treatment success, detect cancer recurrence, and improve patient quality of life.
Researchers develop a method that fuses AlphaFold's strengths with computer simulations based on physics laws to predict protein structures, enabling faster drug development. The approach filters down initial hypotheses to a more manageable set of structures, increasing the effectiveness of pharmaceuticals.
Rural residents with head and neck cancer experience higher mortality rates due to factors like alcohol use, tobacco consumption, and lower HPV vaccination rates. This disparity widens the rural-urban mortality gap.
A study by Ohio State University researchers found that chemotherapy disrupts the gut microbiome in breast cancer patients, leading to cognitive decline and increased inflammation. The research suggests that targeting the gut microbiome may improve behavioral side effects of chemotherapy.
A new AI-powered approach identifies a distinct subset of endometrial cancer with poorer survival rates, but would otherwise go unrecognized. The discovery will help doctors identify patients at high risk of recurrence and death, enabling more comprehensive treatment.
Researchers identified metabolic signatures that predict immunotherapy response and survival outcomes in cancer patients. The study found four distinct metabolic classes with significant variations in overall survival, highlighting the potential of metabolic profiling to improve immunotherapy treatments.
Researchers found associations between childhood cognition, adolescent crystalized intelligence, and midlife fluid intelligence with DNA methylation age acceleration. A 1-unit increase in adolescent PPVT was associated with a 0.048-year decrease in aging.
A new biomarker has been discovered that can help predict which patients with clear cell renal cancer are at higher risk of recurrence. The 15-gene signature was found to be independently associated with worse disease-free survival and disease-specific survival in two large validation datasets.
Researchers found that adding JAK inhibitors to cancer checkpoint inhibitor immunotherapies improves patients' responses in two separate clinical studies. The combination therapy resulted in better clinical responses in patients with metastatic non-small cell lung cancer and those with relapsed or refractory Hodgkin lymphoma.
A new, streamlined urine DNA test detects primary bladder cancer more accurately than current methods, potentially reducing the need for invasive cystoscopy. The test shows high sensitivity and specificity, even for detecting high-grade noninvasive papillary carcinoma.
Researchers have trained an AI model to identify DNA methylation patterns indicative of different cancer types, achieving 98.2% accuracy. This breakthrough could enable early detection and screening of cancers, leading to improved patient outcomes.
Researchers found that lithium's efficacy in enhancing longevity and altering body composition is influenced by the sucrose content of the diet. The study reveals a significant overlap between the transcriptional responses to increasing dietary sucrose and adding lithium, suggesting a joint mechanism at play.
Deep learning enhances STS diagnosis and treatment by automating contouring for radiation therapy and predicting treatment responses. The review highlights key areas where deep learning is making an impact, including data acquisition and processing, algorithm development, clinical applications, and pathological diagnosis.
Ternarx aims to unlock the potential of targeted protein degrader (TPD) technology to treat hard-to-treat cancers like neuroblastoma and prostate cancer. The company will initially focus on developing new treatments for these diseases using novel TPD technology.
Telo-seq reveals dynamic mechanisms of telomeres in aging and cancer, providing new insights into their role in health and disease. The breakthrough method determines telomere length and sequence on individual chromosomes.
Researchers studied cancer survivors under 25 who had cancer since 1958 and found they were three times more likely to develop cancer later in life. Socioeconomic factors also played a role in survival rates, with lower education levels and foreign backgrounds increasing risk.
Dorothee Dormann and Edward Lemke propose a new concept to measure the individual risk of getting age-related diseases by analyzing protein clumps in cells. This 'protein aggregation clock' could help diagnose age-related diseases at early stages or identify people at higher risk.
Researchers have discovered that a protein called MED12 plays a critical role in pancreatic cancer's development, particularly in basal-like cells. The study builds on decades of research at Cold Spring Harbor Laboratory, which previously identified the importance of p63 for basal cell formation.
Families with germline CDH1 P/LP variants show a cumulative risk of gastric cancer between 7-10% and breast cancer in female carriers at 37%
A new trial indicates that immunotherapy could successfully treat the most common form of colorectal cancer. The study, published in Nature Medicine, found that botensilimab and balstilimab caused tumours to shrink or remain stable in 61% of patients with microsatellite stable metastatic colorectal cancer.
Past-year Papanicolaou testing rates dropped in 2022 compared to 2019, highlighting the need to increase access to screenings. Rural-vs-urban differences indicate a focus on rural females requires attention.
Dr Biola M Javierre has been awarded a prestigious grant to study the role of mutations in noncoding regions of the genome in diffuse large B-cell lymphoma (DLBCL). Her research aims to identify genes affected by these mutations and their potential therapeutic targets.
The Kids First DRC has introduced an upgraded data portal to streamline big data search and analysis, improving collaborative pediatric research outcomes. The new portal integrates diverse datasets, including genomic information from the Children's Brain Tumor Network, to foster cross-disciplinary research.
A cohort study found that neighborhood deprivation is associated with increased breast cancer mortality in non-Hispanic white women, but not in non-Hispanic Black women. Factors beyond those explored may contribute to the disparity in breast cancer mortality among Black women.
Generation X sees gains in leading cancers, but lower rates of lung and cervical cancers compared to previous generations. Cancer incidence could remain high for decades if current trends continue.
A study by Cold Spring Harbor Laboratory has discovered two regulator proteins that work together to keep the splicing process on track. The research, led by Professor Adrian Krainer, identifies SRSF1's interactions with other proteins, providing new insights into how this critical regulator works.
A team of researchers has identified the CDA gene as a key player in immunotherapy resistance in pancreatic cancer. Inhibiting this gene improves T-cell infiltration and increases the effectiveness of immunotherapy in a type of pancreatic cancer called PDAC.